-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/phenylketonuria_research-protocol.pdf
March 29, 2011 - Subgroups include the following:
a. infants with PKU
b. children ages 2 to 12 years old with PKU … Subgroups include the following:
a. infants with PKU
b. children ages 2 to 12 years old with PKU … a. infants with PKU
b. children ages 2 to 12 years old with PKU
c. adolescents ages 13-21 years old … a. infants with PKU
b. children ages 2 to 12 years old with PKU
c. adolescents ages 13-21 years old … demographic
clinical
genotypic
adherence
PICOTS
Population
Infants, children ages 2
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-protocol.pdf
February 18, 2023 - Are there special considerations for implementing these models for adults,
children and disadvantaged … ensure appropriate multidisciplinary
representation, including persons with expertise in adult and child … Long-COVID in
children and adolescents: a systematic review and meta-analyses. … Illness duration and symptom profile in
symptomatic UK school-aged children tested for SARS-CoV-2. … Lancet Child Adolesc
Health. 2021 Oct;5(10):708-18. doi: 10.1016/s2352-4642(21)00198-x.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_disposition-comments.pdf
March 01, 2012 - ("Children
are not small adults."). … We agree that
children are not small adults. … Suggesting that this should be used for policy recommendations
risks harming children by restricting … Multiple studies imply that children and older adults
experience different effects when taking AEDs. … For example, it is well
documented that the risk of hepatotoxicity with valproate in
children under
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
January 01, 2024 - related
conditions, including type 2 diabetes
o Hypertension/high blood pressure
Key Question 1
● Children … prospectively
● Studies must specify daily quantity of
PUFA intake
Key Question 1
● For studies in children … of
interest
Both Key Questions
● Specific life stages
o Infants (for Key Question 1 only)
o Children … adults
o Parallel or cross-over randomized
controlled trials (RCTs)
n ≥25/group*
• Studies of children
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
January 01, 2024 - related
conditions, including type 2 diabetes
o Hypertension/high blood pressure
Key Question 1
● Children … • Must specify daily quantity of dietary
saturated fat intake
Key Question 1
● For studies in children … of
interest
Both Key Questions
● Specific life stages
o Infants (for Key Question 1 only)
o Children … adults
o Parallel or cross-over randomized
controlled trials (RCTs)
n ≥25/group*
• Studies of children
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/1-for-children-with-disruptive-behavior-disorders-dbds-including-oppositional-defiant-disorder-odd-conduct-disorder-cd-and-disruptive-behavior-disorder-not-otherwise-specified-dbd-nos-what-is-the-short-term-and-long-term-com
-
effectivehealthcare.ahrq.gov/sites/default/files/celiac-disease_executive.pdf
January 01, 2016 - Young children, in particular,
are susceptible to failure to thrive, stunted
growth, and delayed puberty … Adults (age 18 and over) versus children and
adolescents?
c. … Children under age 24 months versus older children?
d. … under age 24 months versus older children and
adolescents
• Adults (aged 18 and over)
• Ethnic and … High strength of evidence of
accuracy, particularly in children, was found for DGP tests
in recent
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_disposition-comments.pdf
September 10, 2012 - Results after applying
Buteyko techniques to children with asthma for 12 weeks •
Reliever usage – median … /adolescents throughout the report, I wonder if a
separate (albeit short) summary section about
children … Added additional information for children/adolescents
(scant evidence, anecdotal evidence suggests used … hyperven reduction used in children and adol) under
the applicability section of the Executive Summary … , , Fergus Aitcheson Bruce Duncan and Frank
Houghton
Results after applying Buteyko techniques to children
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-201-indoor-allergen-asthma-disposition-comments.pdf
February 15, 2018 - was bothered by
asthma symptoms, and the number of days child was
Thank you for your comments. … Low-income and minority children bear the heaviest
burden of asthma. … within asthma education programs
and home visitor and child care services. … created Wee Wheezers at
Home and Wee Breathers to meet the needs identified
by home visitors and child … TEP Reviewer 4
Methods Table 1 under setting (17 of 173): Does this include
home child care as well
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
March 01, 2022 - and adolescents
(hereafter, we refer to children and adolescents simply
as “children”), adults, and … , and febrile seizures and idiopathic
thrombocytopenic purpura in children. … • Studies on families with children with medically
complex health conditions. … • Studies that examine the effect of technology
among children and adolescents living with chronic … • Few reviews focused on specific settings or
populations other than general adults or children
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
October 12, 2016 - Omega-3 Fatty Acids and Maternal and Child Health: An
Updated Systematic Review. … (Comments pertain to
the maternal studies more than the child studies.) … Prenatal DHA status and
neurological outcome in children at age 5.5 years are
positively associated … Arch
Dis Child 2010; 95:174–179. … However, children who received LC-
PUFAs were faster at
processing information compared with children
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
November 03, 2011 - Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing
Migraine Headaches in Children … NCT00210535 A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine
Attacks in Children … parallel-group randomised placebo-controlled trial of propranolol and
pizotifen in preventing migraine in children
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_espanol.pdf
July 01, 2017 - resumen proviene del informe Psychological and Pharmacologic
Interventions for Disruptive Behavior in Children … conductas disruptivas en niños y adolescentes proviene del reporte
Mental Health Surveillance Among Children … guía fue traducida de la publicación en inglés titulada Treating Disruptive Behavior
Disorders in Children
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - Three studies focused on children and adolescents with low BMD. … One study included male
and female children with osteogenesis imperfecta, a disease characterized by … Developmental
Medicine & Child Neurology 2009 Oct; 51
Suppl 4:166-8.
37. … Low
magnitude mechanical loading is osteogenic
in children with disabling conditions. … diagnosed
with endocrine disorders of
various etiologies and low
bone density; Only children at
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments.pdf
December 23, 2023 - Other, specify ______________
• Population
Pregnant women
Elderly (65 years and older)
Children … each specific intervention within the class, as well as for specific population categories
such as children
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
March 01, 2022 - AHRQ Slide Template
AHRQ Evidence-based Practice Center (EPC) Program
Welcome and thank you for joining the EPC Grand Rounds
Full EPC Report Links
The information provided in this presentation only represents a summary of report data. For detailed information, please visit the AHRQ website links below to read the …
-
effectivehealthcare.ahrq.gov/sites/default/files/s58.pdf
October 01, 2007 - In 2006,
excluding State Child Health Insurance Program (SCHIP)
participants, an estimated 56.3 million … individuals were en-
rolled,4 or almost 1 in 5 Americans, including 31.1 million
children, 16.2 million … and adults; in children and adolescents,
antidepressant drug treatment was associated with both out- … A profile of children with
disabilities receiving SSI: highlights from the National Survey of SSI
Children … Antidepressant drug therapy and
suicide in severely depressed children and adults: a case-control study
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-pharmacologic-treatment_research-protocol.pdf
December 27, 2016 - effectiveness of intermittent ICS compared to
no treatment, pharmacologic or non-pharmacologic therapy in children … • KQ1a: Children 0 to 4 years of age with recurrent wheezing
• KQ1b-c: Patients 5 years of age and … Inclusion and exclusion criteria
Category Inclusion Criteria Exclusion Criteria
Population KQ1a: Children … Emerging issues in pediatric asthma: gaps in EPR-3 guidelines for
infants and children. … older
Pulmicort Respules (budesonide) Maintenance treatment of asthma as prophylactic therapy in children
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-safety-practices-rapid-protocol.pdf
September 09, 2022 - real-time
clinical encounter involving two-way
live video conferencing between
patient and clinician
• Children … (age < 18 years) and
caregivers for children
• Adults receiving in-patient or
emergency department
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_disposition-comments.pdf
January 01, 2010 - They emphasized the
difficulties of school-age children receiving
pre-lunch insulin injections and … the stress
thereby induced in these children and their
parents. … Reviewer 4 Abstract Page iv, line 32; to be more clear, the
sentence should state that “In children … The
frequency of blood glucose monitoring
depends on the population (children, adults,
adolescents … MDI in terms
of HbA1c improvement is proven in patients
with type 1 diabetes (children, adolescents